University of Veterinary Medicine Vienna - Research portal

Kenner Lukas,

** = Publications listed in SCI/SSCI/Pubmed

2021

Journal Article

** Aksoy, O; Pencik, J; Hartenbach, M; Moazzami, AA; Schlederer, M; Balber, T; Varady, A; Philippe, C; Baltzer, PA; Mazumder, B; Whitchurch, JB; Roberts, CJ; Haitel, A; Herac, M; Susani, M [and 22 others] (2021): Thyroid and androgen receptor signaling are antagonized by CRYM in prostate cancer. Int J Cancer. 2021 148 (3) 731-747.

** Bierbaumer, L; Katschnig, AM; Radic-Sarikas, B; Kauer, MO; Petro, JA; Högler, S; Gurnhofer, E; Pedot, G; Schäfer, BW; Schwentner, R; Mühlbacher, K; Kromp, F; Aryee, DNT; Kenner, L; Uren, A; Kovar, H (2021): YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells. Oncogenesis. 2021; 10(1):2
Open Access Logo

** Forde, S; Matthews, JD; Jahangiri, L; Lee, LC; Prokoph, N; Malcolm, TIM; Giger, OT; Bell, N; Blair, H; O'Marcaigh, A; Smith, O; Kenner, L; Bomken, S; Burke, GAA; Turner, SD (2021): Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy. Br J Haematol. 2021 192 (2) 354-365.
Open Access Logo

** Guo, J; Johnson, H; Zhang, X; Feng, X; Zhang, H; Simoulis, A; Wu, AH; Xia, T; Li, F; Tan, W; Johnson, A; Dizeyi, N; Abrahamsson, PA; Kenner, L; Chen, L [and 4 others] (2021): A 23-Gene Classifier urine test for prostate cancer prognosis. Clin Transl Med. 2021; 11(3):e340
Open Access Logo

** Paolino, M; Koglgruber, R; Cronin, SJF; Uribesalgo, I; Rauscher, E; Harreiter, J; Schuster, M; Bancher-Todesca, D; Pranjic, B; Novatchkova, M; Fededa, JP; White, AJ; Sigl, V; Dekan, S; Penz, T [and 6 others] (2021): RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy. Nature. 2021; 589(7842):442-447

** Poelzl, A; Lassnig, C; Tangermann, S; Hromadová, D; Reichart, U; Gawish, R; Mueller, K; Moriggl, R; Linkermann, A; Glösmann, M; Kenner, L; Mueller, M; Strobl, B (2021): TYK2 licenses non-canonical inflammasome activation during endotoxemia. Cell Death Differ. 2021 28 (2) 748-763.

** Redl, E; Sheibani-Tezerji, R; Cardona, CJ; Hamminger, P; Timelthaler, G; Hassler, MR; Zrimšek, M; Lagger, S; Dillinger, T; Hofbauer, L; Draganić, K; Tiefenbacher, A; Kothmayer, M; Dietz, CH; Ramsahoye, BH [and 6 others] (2021): Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis. Life Sci Alliance. 2021; 4(2):e202000794
Open Access Logo

** Schnoell, J; Jank, BJ; Kadletz-Wanke, L; Stoiber, S; Spielvogel, CP; Gurnhofer, E; Kenner, L; Heiduschka, G (2021): Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort. J Cancer Res Clin Oncol. 2021 147 (3) 755-765.
Open Access Logo

** Swoboda, A; Soukup, R; Eckel, O; Kinslechner, K; Wingelhofer, B; Schörghofer, D; Sternberg, C; Pham, HTT; Vallianou, M; Horvath, J; Stoiber, D; Kenner, L; Larue, L; Poli, V; Beermann, F [and 12 others] (2021): STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway. Oncogene. 2021 40 (6) 1091-1105.

** Valent, P; Orfao, A; Kubicek, S; Staber, P; Haferlach, T; Deininger, M; Kollmann, K; Lion, T; Virgolini, I; Winter, G; Hantschel, O; Kenner, L; Zuber, J; Grebien, F; Moriggl, R [and 11 others] (2021): Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions. Hemasphere. 2021; 5(3):e536
Open Access Logo

** Zhou, Y; Bastian, IN; Long, MD; Dow, M; Li, W; Liu, T; Ngu, RK; Antonucci, L; Huang, JY; Phung, QT; Zhao, XH; Banerjee, S; Lin, XJ; Wang, H; Dang, B [and 18 others] (2021): Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. Proc Natl Acad Sci U S A. 2021; 118(8):e2025840118

2020

** Atas, E; Oberhuber, M; Kenner, L (2020): The Implications of PDK1-4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance. Front Oncol. 2020; 10:583217
Open Access Logo

** Beiglböck, H; Wolf, P; Pfleger, L; Caliskan, B; Fellinger, P; Zettinig, G; Anderwald, CH; Kenner, L; Trattnig, S; Kautzky-Willer, A; Krššák, M; Krebs, M (2020): Effects of thyroid function on phosphodiester concentrations in skeletal muscle and liver: An in vivo NMRS study. J Clin Endocrinol Metab. 2020; 105(12):dgaa663

** Gruber, ES; Oberhuber, G; Pils, D; Stork, T; Sinn, K; Gruber, S; Nica, R; Kolmer, D; Turner, SD; Schlederer, M; Widder, J; Doerr, W; Teleky, B; Kenner, L (2020): The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray. Cancers (Basel). 2020; 12(3):563
Open Access Logo

** Jank, BJ; Kadletz, L; Dunkler, D; Haas, M; Schnoell, J; Kenner, L; Heiduschka, G (2020): Epithelial stem cell marker LGR6 expression identifies a low-risk subgroup in human papillomavirus positive oropharyngeal squamous cell carcinoma. Oral Oncol. 2020; 105:104657

** Johnson, H; Guo, J; Zhang, X; Zhang, H; Simoulis, A; Wu, AHB; Xia, T; Li, F; Tan, W; Johnson, A; Dizeyi, N; Abrahamsson, PA; Kenner, L; Feng, X; Zou, C [and 3 others] (2020): Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up. BMC Med. 2020; 18(1):376
Open Access Logo

** Kadletz, LC; Brkic, FF; Jank, BJ; Schneider, S; Cede, J; Seemann, R; Gruber, ES; Gurnhofer, E; Heiduschka, G; Kenner, L (2020): AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck. Pathol Oncol Res. 2020; 26(2):1287-1292
Open Access Logo

** Lim, MS; Beyer, T; Babayan, A; Bergmann, M; Brehme, M; Buyx, A; Czernin, J; Egger, G; Elenitoba-Johnson, KSJ; Gückel, B; Jačan, A; Haslacher, H; Hicks, RJ; Kenner, L; Langanke, M [and 13 others] (2020): Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria. Mol Imaging Biol. 2020; 22(1):47-65
Open Access Logo

** Maurer, B; Nivarthi, H; Wingelhofer, B; Pham, HTT; Schlederer, M; Suske, T; Grausenburger, R; Schiefer, AI; Prchal-Murphy, M; Chen, D; Winkler, S; Merkel, O; Kornauth, C; Hofbauer, M; Hochgatterer, B [and 23 others] (2020): High activation of STAT5A drives peripheral T-cell lymphoma and leukemia. Haematologica. 2020; 105(2):435-447
Open Access Logo

** Oberhuber, M; Pecoraro, M; Rusz, M; Oberhuber, G; Wieselberg, M; Haslinger, P; Gurnhofer, E; Schlederer, M; Limberger, T; Lagger, S; Pencik, J; Kodajova, P; Högler, S; Stockmaier, G; Grund-Gröschke, S [and 18 others] (2020): STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer. Mol Syst Biol. 2020; 16(4):e9247
Open Access Logo

** Pflügler, S; Svinka, J; Scharf, I; Crncec, I; Filipits, M; Charoentong, P; Tschurtschenthaler, M; Kenner, L; Awad, M; Stift, J; Schernthanner, M; Bischl, R; Herndler-Brandstetter, D; Glitzner, E; Moll, HP [and 13 others] (2020): IDO1 + Paneth Cells Promote Immune Escape of Colorectal Cancer. Commun Biol. 2020; 3(1):252
Open Access Logo

** Prokoph, N; Probst, NA; Lee, LC; Monahan, JM; Matthews, JD; Liang, HC; Bahnsen, K; Montes-Mojarro, IA; Karaca-Atabay, E; Sharma, GG; Malik, V; Larose, H; Forde, SD; Ducray, SP; Lobello, C [and 24 others] (2020): IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma. Blood. 2020; 136(14):1657-1669

** Schnoell, J; Kadletz, L; Jank, BJ; Oberndorfer, F; Brkic, FF; Gurnhofer, E; Cede, J; Seemann, R; Kenner, L; Heiduschka, G (2020): Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause-specific survival. Clin Otolaryngol. 2020 45 (3) 364-369.
Open Access Logo

** Tobias, J; Battin, C; De Sousa Linhares, A; Lebens, M; Baier, K; Ambroz, K; Drinić, M; Högler, S; Inic-Kanada, A; Garner-Spitzer, E; Preusser, M; Kenner, L; Kundi, M; Zielinski, CC; Steinberger, P; Wiedermann, U (2020): A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors. Front Immunol. 2020; 11:895
Open Access Logo

** Vizzardelli, C; Zimmann, F; Nagl, B; Kitzmüller, C; Vollmann, U; Gindl, M; Tangermann, S; Jahn-Schmid, B; Kenner, L; Bohle, B (2020): NSG mice humanized with allergen-specific T-cell lines as in vivo model of respiratory allergy. Allergy. 2020 75 (8) 2081-2084.
Open Access Logo

Conference Paper in Journal

** Neubauer, HA; Suske, T; Schonefeldt, S; Tangermann, S; Boersma, A; Rulicke, T; Bekiaris, V; Kenner, L; Moriggl, R (2020): The gain-of-function STAT5B(N642H) mutation as a driver of mature T cell leukemia/lymphoma. AACR Annual Meeting, Philadelphia, PA, United States, JUN 22-24, 2020. Cancer Res (80), 16 2752.

2019

Journal Article

** Aigner, P; Mizutani, T; Horvath, J; Eder, T; Heber, S; Lind, K; Just, V; Moll, HP; Yeroslaviz, A; Fischer, MJM; Kenner, L; Győrffy, B; Sill, H; Grebien, F; Moriggl, R [and 2 others] (2019): STAT3β is a tumor suppressor in acute myeloid leukemia. Blood Adv. 2019; 3(13):1989-2002
Open Access Logo

** de Araujo, ED; Erdogan, F; Neubauer, HA; Meneksedag-Erol, D; Manaswiyoungkul, P; Eram, MS; Seo, HS; Qadree, AK; Israelian, J; Orlova, A; Suske, T; Pham, HTT; Boersma, A; Tangermann, S; Kenner, L [and 9 others] (2019): Structural and functional consequences of the STAT5B Nat Commun. 2019; 10(1):2517
Open Access Logo

** Fitzal, F; Turner, SD; Kenner, L (2019): Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery? Open Biol. 2019; 9(4):190006
Open Access Logo

** Gruber, ES; Oberhuber, G; Birner, P; Schlederer, M; Kenn, M; Schreiner, W; Jomrich, G; Schoppmann, SF; Gnant, M; Tse, W; Kenner, L (2019): The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells. 2019; 8(11):1357
Open Access Logo

** Kadletz, L; Kenner, L; Wiebringhaus, R; Jank, B; Mayer, C; Gurnhofer, E; Konrad, S; Heiduschka, G (2019): Evaluation of the cancer stem cell marker DCLK1 in patients with lymph node metastases of head and neck cancer. Pathol Res Pract. 2019; 215(12):152698

** Kaltenecker, D; Themanns, M; Mueller, KM; Spirk, K; Golob-Schwarzl, N; Friedbichler, K; Kenner, L; Haybaeck, J; Moriggl, R (2019): STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. Cytokine. 2019; 124:154573
Open Access Logo

** Kaltenecker, D; Themanns, M; Mueller, KM; Spirk, K; Suske, T; Merkel, O; Kenner, L; Luís, A; Kozlov, A; Haybaeck, J; Müller, M; Han, X; Moriggl, R (2019): Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression. Cytokine. 2019; 124:154569
Open Access Logo

** Kotowski, U; Kadletz, L; Schneider, S; Oberndorfer, F; Schnoell, J; Gurnhofer, E; Kenner, L; Lucas, T; Heiduschka, G (2019): Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma. Sci Rep. 2019; 9(1):18866
Open Access Logo

** Prutsch, N; Gurnhofer, E; Suske, T; Liang, HC; Schlederer, M; Roos, S; Wu, LC; Simonitsch-Klupp, I; Alvarez-Hernandez, A; Kornauth, C; Leone, DA; Svinka, J; Eferl, R; Limberger, T; Aufinger, A [and 18 others] (2019): Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma. Leukemia. 2019; 33(3):696-709

** Rao, S; Mondragón, L; Pranjic, B; Hanada, T; Stoll, G; Köcher, T; Zhang, P; Jais, A; Lercher, A; Bergthaler, A; Schramek, D; Haigh, K; Sica, V; Leduc, M; Modjtahedi, N [and 17 others] (2019): AIF-regulated oxidative phosphorylation supports lung cancer development. Cell Res. 2019; 29(7):579-591
Open Access Logo

** Sperling, S; Fiedler, P; Lechner, M; Pollithy, A; Ehrenberg, S; Schiefer, AI; Kenner, L; Feuchtinger, A; Kühn, R; Swinerd, G; Schmidt-Supprian, M; Strobl, LJ; Zimber-Strobl, U (2019): Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells Blood. 2019; 133(24): 2597-2609.

** Trigg, RM; Lee, LC; Prokoph, N; Jahangiri, L; Reynolds, CP; Amos Burke, GA; Probst, NA; Han, M; Matthews, JD; Kai Lim, H; Manners, E; Martinez, S; Pastor, J; Blanco-Aparicio, C; Merkel, O [and 7 others] (2019): The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status. Nat Commun. 2019; 10(1):5428
Open Access Logo

Haug, A; Kenner, L (2019): Weniger invasive Biopsien für den Krebspatienten? Jatros / Hämatologie & Onkologie 2019; 19(2): 23-24.

Conference Paper in Journal

** Andrukhova, O; Latic, N; Radloff, J; Slavic, S; Endler, L; Murali, S; Bayer, J; Zeitz, U; Pfeiffenberger, U; Tangermann, S; Lagger, S; Wilflingseder, J; Kenner, L; Strobl, B; Erben, R [and 3 others] (2019): FGF23 Promotes Disease Progression in 5/6-Nephrectomized Mice By WNK and Proinflammatory Signaling. Annual Meeting of the American-Society-for-Bone-and Mineral Research, Orlando, FL, United States, SEP 20-23, 2019. J Bone Miner Res (34), S1 57-58.

** Ducray, SP; Trigg, R; Bannister, AJ; Lai, R; Egger, G; Merkel, O; Kenner, L; Turner, S (2019): The Identification of Novel Epigenetic Therapies for ALK-Driven Haematological Malignancies. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, United States, DEC 07-10, 2019. Blood (134), S1 1483.

** Staber, PB; Kornauth, C; Alonso, IGD; Woessmann, W; Klapper, W; Lagger, S; Schiefer, AI; Skrabs, C; Merkel, O; Mayerhoefer, ME; Greil, R; Simonitsch-Klupp, I; Kenner, L; Jaeger, U (2019): Imatinib plus /- Brentuximab Vedotin Induces Sustained Complete Remission in Chemotherapy-Resistant Anaplastic Large Cell Lymphoma Expressing PDGFR. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, United States, DEC 07-10, 2019. Blood (134), S1 4037.

** Tobias, J; Battin, C; Linhares, AD; Lebens, M; Baier, K; Ambroz, K; Hoegler, S; Inic-Kanada, A; Garner-Spitzer, E; Preusser, M; Kenner, L; Kundi, M; Zielinski, CC; Steinberger, P; Wiedermann, U (2019): Active immunization with immune checkpoint inhibitors-mimotope elicits strong anti-tumour effect against HER-2/neu-expressing tumours. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, SEP 27-OCT 01, 2019. Ann Oncol (30), S5 480-480.

2018

Journal Article

** Crnčec, I; Modak, M; Gordziel, C; Svinka, J; Scharf, I; Moritsch, S; Pathria, P; Schlederer, M; Kenner, L; Timelthaler, G; Müller, M; Strobl, B; Casanova, E; Bayer, E; Mohr, T [and 3 others] (2018): STAT1 is a sex-specific tumor suppressor in colitis-associated colorectal cancer. Mol Oncol 12(4): 514-528.
Open Access Logo

** Garces de Los Fayos Alonso, I; Liang, HC; Turner, SD; Lagger, S; Merkel, O; Kenner, L (2018): The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas. Cancers (Basel). 2018; 10(4): 93.
Open Access Logo

** Grubmüller, B; Baltzer, P; Hartenbach, S; D"Andrea, D; Helbich, TH; Haug, AR; Goldner, GM; Wadsak, W; Pfaff, S; Mitterhauser, M; Balber, T; Berroteran-Infante, N; Grahovac, M; Babich, J; Seitz, C [and 7 others] (2018): PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact Clin Cancer Res. 2018; 24(24): 6300-6307.

** Gutjahr, JC; Szenes, E; Tschech, L; Asslaber, D; Schlederer, M; Roos, S; Yu, X; Girbl, T; Sternberg, C; Egle, A; Aberger, F; Alon, R; Kenner, L; Greil, R; Orian-Rousseau, V; Hartmann, TN (2018): Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia. Blood. 2018; 131(12):1337-1349
Open Access Logo

** Hacker, M; Hoermann, G; Kenner, L (2018): Molecular imaging and molecular diagnostics: two sides of the same coin? Eur J Nucl Med Mol Imaging. 2018; 45(10):1645-1648

** Neunkirchner, A; Kratzer, B; Köhler, C; Smole, U; Mager, LF; Schmetterer, KG; Trapin, D; Leb-Reichl, V; Rosloniec, E; Naumann, R; Kenner, L; Jahn-Schmid, B; Bohle, B; Valenta, R; Pickl, WF (2018): Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice. EBioMedicine. 2018; 31:66-78
Open Access Logo

** Pham, HTT; Maurer, B; Prchal-Murphy, M; Grausenburger, R; Grundschober, E; Javaheri, T; Nivarthi, H; Boersma, A; Kolbe, T; Elabd, M; Halbritter, F; Pencik, J; Kazemi, Z; Grebien, F; Hengstschläger, M [and 9 others] (2018): STAT5BN642H is a driver mutation for T cell neoplasia. J Clin Invest. 2018; 128(1):387-401
Open Access Logo

** Schleussner, N; Merkel, O; Costanza, M; Liang, HC; Hummel, F; Romagnani, C; Durek, P; Anagnostopoulos, I; Hummel, M; Jöhrens, K; Niedobitek, A; Griffin, PR; Piva, R; Sczakiel, HL; Woessmann, W [and 14 others] (2018): The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma. Leukemia. 2018; 32(9):1994-2007
Open Access Logo

** Schmidt, S; Schumacher, N; Schwarz, J; Tangermann, S; Kenner, L; Schlederer, M; Sibilia, M; Linder, M; Altendorf-Hofmann, A; Knösel, T; Gruber, ES; Oberhuber, G; Bolik, J; Rehman, A; Sinha, A [and 18 others] (2018): ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling. J Exp Med. 2018; 215(4):1205-1225
Open Access Logo

** Schneider, S; Kadletz, L; Wiebringhaus, R; Kenner, L; Selzer, E; Füreder, T; Rajky, O; Berghoff, AS; Preusser, M; Heiduschka, G (2018): PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome. Histopathology. 2018; 73(4):573-584

** Shirsath, N; Wagner, K; Tangermann, S; Schlederer, M; Ringel, C; Kenner, L; Brüne, B; Wolf, P (2018): 8-Methoxypsoralen Plus Ultraviolet A Reduces the Psoriatic Response to Imiquimod in a Murine Model. Acta Derm-Venereol. 2018; 98(6): 576-584.
Open Access Logo

** Sternberg, C; Gruber, W; Eberl, M; Tesanovic, S; Stadler, M; Elmer, DP; Schlederer, M; Grund, S; Roos, S; Wolff, F; Kaur, S; Mangelberger, D; Lehrach, H; Hache, H; Wierling, C [and 9 others] (2018): Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma. Int J Cancer. 2018; 143(11):2943-2954
Open Access Logo

** Vizzardelli, C; Gindl, M; Roos, S; Möbs, C; Nagl, B; Zimmann, F; Sexl, V; Kenner, L; Neunkirchner, A; Zlabinger, GJ; Pickl, WF; Pfützner, W; Bohle, B (2018): Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model. Allergy. 2018; 73(4):851-861

Kenner, L; Hacker, M (2018): Sammlung und Nutzung klinischer Patientendaten alsGrundlage computergestützter klinischer Assistenzsysteme. Zeitschrift für medizinische Ethik 2018; : 167-170.

Conference Paper in Journal

** Alonso, IGD; Kothmayer, M; Schlederer, M; Pusch, O; Tangermann, S; Lagger, S; Kenner, L (2018): Examining the function of PDGFRB in anaplastic large cell lymphoma. 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, SEP 26-29, 2018. Brit J Haematol (182), S1 29-30.

** Ducray, SP; Garland, GD; Truong, T; Prokoph, N; Elenitoba-Johnson, KSJ; Lim, MS; Merkel, O; Kenner, L; Bannister, A; Turner, SD (2018): The anaplastic large cell lymphoma (ALCL)-associated nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) directs expression of the nuclear protein brahma related gene 1 (BRG1) driving cell survival. 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, SEP 26-29, 2018. Brit J Haematol (182), S1 30-30.

** Larose, H; Mian, S; Nuglozeh, E; Fazaludeen, FMS; Elmouna, A; Ashankyty, I; Du, MQ; Hoefler, G; Pospisilova, S; Woessmann, W; Damm-Welk, C; Fedorova, A; Lamant, L; Schlederer, M; Merkel, O [and 2 others] (2018): Investigating the functional impact of single nucleotide variants in anaplastic large cell lymphoma. 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, SEP 26-29, 2018. Brit J Haematol (182), S1 41-42.

** Liang, HC; Prutsch, N; Gurnhofer, E; Timelthaler, G; Eferl, R; Tangermann, S; Horvath, J; Stoiber, D; Mathas, S; Kenner, L; Merkel, O (2018): The AP-1-BATF and-BATF3 module: divergent roles in tumour growth, invasion and angiogenesis in anaplastic large cell lymphoma. 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, SEP 26-29, 2018. Brit J Haematol (182), S1 43-43.

2017

Journal Article

** Balendran, S; Liebmann-Reindl, S; Berghoff, AS; Reischer, T; Popitsch, N; Geier, CB; Kenner, L; Birner, P; Streubel, B; Preusser, M (2017): Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations. J Neurooncol. 2017; 133(3):469-476
Open Access Logo

** Boidol, B; Kornauth, C; van der Kouwe, E; Prutsch, N; Kazianka, L; Gültekin, S; Hoermann, G; Mayerhoefer, ME; Hopfinger, G; Hauswirth, A; Panny, M; Aretin, MB; Hilgarth, B; Sperr, WR; Valent, P [and 7 others] (2017): First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia. Blood. 2017; 130(23):2499-2503

** Ebner, F; Sedlyarov, V; Tasciyan, S; Ivin, M; Kratochvill, F; Gratz, N; Kenner, L; Villunger, A; Sixt, M; Kovarik, P (2017): The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection. J Clin Invest. 2017; 127(6):2051-2065
Open Access Logo

** Greiner, G; Witzeneder, N; Berger, A; Schmetterer, K; Eisenwort, G; Schiefer, AI; Roos, S; Popow-Kraupp, T; Müllauer, L; Zuber, J; Sexl, V; Kenner, L; Sperr, WR; Valent, P; Mayerhofer, M; Hoermann, G (2017): CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis. Blood. 2017; 129(3):371-382

** Kadletz, L; Heiduschka, G; Wiebringhaus, R; Gurnhofer, E; Kotowski, U; Haymerle, G; Brunner, M; Barry, C; Kenner, L (2017): ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report. Cell Oncol (Dordr). 2017; 40(2):193-198

** Kadletz, L; Thurnher, D; Wiebringhaus, R; Erovic, BM; Kotowski, U; Schneider, S; Schmid, R; Kenner, L; Heiduschka, G (2017): Role of cancer stem-cell marker doublecortin-like kinase 1 in head and neck squamous cell carcinoma. Oral Oncol. 2017; 67:109-118

** Kaltenecker, D; Mueller, KM; Benedikt, P; Feiler, U; Themanns, M; Schlederer, M; Kenner, L; Schweiger, M; Haemmerle, G; Moriggl, R (2017): Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice. Diabetologia (60), 2 296-305.
Open Access Logo

** Mahendrarajah, N; Borisova, ME; Reichardt, S; Godmann, M; Sellmer, A; Mahboobi, S; Haitel, A; Schmid, K; Kenner, L; Heinzel, T; Beli, P; Krämer, OH (2017): HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3. Cell Signal. 2017; 39:9-17

** Merkel, O; Taylor, N; Prutsch, N; Staber, PB; Moriggl, R; Turner, SD; Kenner, L (2017): When the guardian sleeps: Reactivation of the p53 pathway in cancer. Mutat Res. 2017; 773:1-13

** Minas, TZ; Surdez, D; Javaheri, T; Tanaka, M; Howarth, M; Kang, HJ; Han, J; Han, ZY; Sax, B; Kream, BE; Hong, SH; Çelik, H; Tirode, F; Tuckermann, J; Toretsky, JA [and 8 others] (2017): Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model. Oncotarget. 2017; 8(21):34141-34163
Open Access Logo

** Nizet, S; Muñoz, E; Fiebich, BL; Abuja, PM; Kashofer, K; Zatloukal, K; Tangermann, S; Kenner, L; Tschegg, C; Nagl, D; Scheichl, L; Meisslitzer-Ruppitsch, C; Freissmuth, M; Berger, T (2017): Clinoptilolite in Dextran Sulphate Sodium-Induced Murine Colitis: Efficacy and Safety of a Microparticulate Preparation. Inflamm Bowel Dis. 2017; 24(1):54-66
Open Access Logo

** Rao, S; Sigl, V; Wimmer, RA; Novatchkova, M; Jais, A; Wagner, G; Handschuh, S; Uribesalgo, I; Hagelkruys, A; Kozieradzki, I; Tortola, L; Nitsch, R; Cronin, SJ; Orthofer, M; Branstetter, D [and 16 others] (2017): RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer. Genes Dev. 2017; 31(20):2099-2112
Open Access Logo

** Riedl, A; Schlederer, M; Pudelko, K; Stadler, M; Walter, S; Unterleuthner, D; Unger, C; Kramer, N; Hengstschläger, M; Kenner, L; Pfeiffer, D; Krupitza, G; Dolznig, H (2017): Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses. J Cell Sci. 2017; 130(1):203-218

** Sackmann Sala, L; Boutillon, F; Menara, G; De Goyon-Pélard, A; Leprévost, M; Codzamanian, J; Lister, N; Pencik, J; Clark, A; Cagnard, N; Bole-Feysot, C; Moriggl, R; Risbridger, GP; Taylor, RA; Kenner, L [and 2 others] (2017): A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours. J Pathol. 2017; 243(1):51-64

** Snijder, B; Vladimer, GI; Krall, N; Miura, K; Schmolke, AS; Kornauth, C; Lopez de la Fuente, O; Choi, HS; van der Kouwe, E; Gültekin, S; Kazianka, L; Bigenzahn, JW; Hoermann, G; Prutsch, N; Merkel, O [and 19 others] (2017): Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study. Lancet Haematol. 2017; 4(12):e595-e606
Open Access Logo

** Srivatsa, S; Paul, MC; Cardone, C; Holcmann, M; Amberg, N; Pathria, P; Diamanti, MA; Linder, M; Timelthaler, G; Dienes, HP; Kenner, L; Wrba, F; Prager, GW; Rose-John, S; Eferl, R [and 6 others] (2017): EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients. Gastroenterology. 2017; 153(1):178-190.e10
Open Access Logo

** Stanclova, G; Schwendenwein, I; Merkel, O; Kenner, L; Dittami, J; Fritz, J; Scope, A (2017): The Effects Of Migratory Flight On Hematologic Parameters In Northern Bald Ibises (Geronticus Eremita). J Zoo Wildlife Med (48), 4 1154-1164.

** Taniguchi, K; Moroishi, T; de Jong, PR; Krawczyk, M; Grebbin, BM; Luo, H; Xu, RH; Golob-Schwarzl, N; Schweiger, C; Wang, K; Di Caro, G; Feng, Y; Fearon, ER; Raz, E; Kenner, L [and 6 others] (2017): YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis. Proc Natl Acad Sci U S A. 2017; 114(7):1643-1648
Open Access Logo

** Taylor, N; Kremser, I; Auer, S; Hoermann, G; Greil, R; Haschke-Becher, E; Esterbauer, H; Kenner, L; Oberkofler, H (2017): Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients. J Acquir Immune Defic Syndr. 2017; 75(1):e13-e20
Open Access Logo

** Unger, C; Kramer, N; Unterleuthner, D; Scherzer, M; Burian, A; Rudisch, A; Stadler, M; Schlederer, M; Lenhardt, D; Riedl, A; Walter, S; Wernitznig, A; Kenner, L; Hengstschläger, M; Schüler, J [and 2 others] (2017): Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms. Oncogene. 2017; 36(38):5341-5355

** Valent, P; Akin, C; Arock, M; Bock, C; George, TI; Galli, SJ; Gotlib, J; Haferlach, T; Hoermann, G; Hermine, O; Jäger, U; Kenner, L; Kreipe, H; Majeti, R; Metcalfe, DD [and 8 others] (2017): Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal. EBioMedicine. 2017; 26:17-24
Open Access Logo

** Yotova, I; Hsu, E; Do, C; Gaba, A; Sczabolcs, M; Dekan, S; Kenner, L; Wenzl, R; Tycko, B (2017): Epigenetic Alterations Affecting Transcription Factors and Signaling Pathways in Stromal Cells of Endometriosis. PLoS One. 2017; 12(1):e0170859
Open Access Logo

Conference Paper in Journal

** Balber, T; Aksoy, O; Merkel, O; Kenner, L; Hartenbach, M; Berroteran-Infante, N; Wadsak, W; Hacker, M; Mitterhauser, M (2017): In vitro uptake of [F-18]FEC, [I-125]T3 and [C-14]Testosterone in CRYM-overexpressing prostate cancer cell lines. 22nd International Symposium on Radiopharmaceutical Sciences (ISRS 2017), Dresden, Germany, May 14‐19, 2017. J Labelled Compd Rad (60), S1 S192-S192.

** Dillinger, T; Redl, E; Pulverer, W; Sprinzl, B; Hassler, MR; Scheibelreiter, J; Afarani, HS; Kenner, L; Weinhausel, A; Egger, G (2017): Identification of Biomarkers for Prostate Cancer by DNA Methylation Analysis. 1st Global Congress on Molecular Pathology, Berlin, Germany, APR 3-5, 2017. J Mol Diagn (19), 2S S40-S41.

** Shirsath, N; Wagner, K; Ober, J; Mayer, G; Schlederer, M; Roos, S; Kenner, L; Wolf, P (2017): PUVA diminishes imiquimod-induced psoriatic phenotype with gene expression signature associated with senescence. 47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR), Salzburg, AUSTRIA, Austria, SEP 27-30, 2017. J Invest Dermatol (137), 10 S301-S301.

Greiner, G; Witzeneder, N; Berger, A; Schmetterer, K; Eisenworth, G; Schiefer, A; Roos, S; Popow-kraupp, T; Müllauer, L; Zuber, J; Sexl, V; Kenner, L; Sperr, WR; Mayerhofer, M; Valent, P; Hoermann, G (2017): ccl-2 Is A Kit D816v-dependent Modulator Of The Bone Marrow Microenvironment In Systemic Mastocytosis: Cod: T210. Euromedlab 2017 Athen, Athen, Greece, June 11-15, 2017. Clinical Chemistry and Laboratory Medicine (55) 709-709.

Gruber, ES; Birner, P; Merkel, O; Bergmann, M; Schoppmann, SF; Park, J; Moriggl, R; Tse, W; Kenner, L (2017): The coactivator oncogene AF1Q associates with STAT3 activation downstream of MET action in gastro-esophageal cancer patients. AACR, Washington DC, United States, April 1-5, 2017. Cancer Research (70), 13 4463-4463.

Kadletz, L; Kenner, L; Poyntner, L; Formanek, M; Primosch, T; Schartinger, V; Brunner, M (2017): Postoperative radiotherapy versus surgery alone for T1N1 and T2N0 oropharygeal squamous cell carcinoma: a nationwide and retrospective study. ECCO European Cancer Congress, Amsterdam, Netherlands, Jan 27-30, 2017. European Journal Of Cancer (72) 104-104.

Prutsch, N; Sanda, T; Wu, L; Turner, S; Jaeger, U; Staber, P; Steinberger, P; Moriggl, R; Mueller, M; Kenner, L; Merkel, O (2017): The TYK2-STAT1 pathway in aggressive T-Cell Lymphoma: A new therapeutic intervention site? ÖGBMT, Innsbruck, Austria, Sep 25-27, 2017. Oncology Research And Treatment (40) 239-239.

Staber, P; Snijder, B; Vladimer, G; Krall, N; Miura, K; Schmolke, AS; Kornauth, C; Lopez de la Fuente, O; Choi, N; van der Kouwe, E; , Kazianka; Bigenzahn, J; Hoermann, G; Prutsch, N; Merkel, O [and 16 others] (2017): Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies. American Society of Hematology, San Diego, United States, Dec 7 2017. Blood (130), 1 855-855.

2016

Journal Article

** Bauer, E; Schlederer, M; Scheicher, R; Horvath, J; Aigner, P; Schiefer, AI; Kain, R; Regele, H; Hoermann, G; Steiner, G; Kenner, L; Sexl, V; Villunger, A; Moriggl, R; Stoiber, D (2016): Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice. Oncotarget. 2016; 7(11):12191-12205
Open Access Logo

** Birner, P; Heider, S; Petzelbauer, P; Wolf, P; Kornauth, C; Kuroll, M; Merkel, O; Steiner, G; Kishimoto, T; Rose-John, S; Soleiman, A; Moriggl, R; Kenner, L (2016): Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus. Exp Dermatol. 2016; 25(4):305-310
Open Access Logo

** Culig, Z; Pencik, J; Merkel, O; Kenner, L (2016): Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expression. Mol Cell Oncol. 2016; 3(2):e1090048
Open Access Logo

** Hassler, MR; Pulverer, W; Lakshminarasimhan, R; Redl, E; Hacker, J; Garland, GD; Merkel, O; Schiefer, AI; Simonitsch-Klupp, I; Kenner, L; Weisenberger, DJ; Weinhaeusel, A; Turner, SD; Egger, G (2016): Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling. Cell Rep. 2016; 17(2):596-608
Open Access Logo

** Javaheri, T; Kazemi, Z; Pencik, J; Pham, HT; Kauer, M; Noorizadeh, R; Sax, B; Nivarthi, H; Schlederer, M; Maurer, B; Hofbauer, M; Aryee, DN; Wiedner, M; Tomazou, EM; Logan, M [and 10 others] (2016): Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation. Cell Death Dis. 2016; 7(10):e2419
Open Access Logo

** Kollmann, K; Heller, G; Schneckenleithner, C; Warsch, W; Scheicher, R; Ott, RG; Schäfer, M; Fajmann, S; Schlederer, M; Schiefer, AI; Reichart, U; Mayerhofer, M; Hoeller, C; Zöchbauer-Müller, S; Kerjaschki, D [and 9 others] (2016): A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis. Cancer Cell 30(2): 359-360.

** Malcolm, TI; Villarese, P; Fairbairn, CJ; Lamant, L; Trinquand, A; Hook, CE; Burke, GA; Brugières, L; Hughes, K; Payet, D; Merkel, O; Schiefer, AI; Ashankyty, I; Mian, S; Wasik, M [and 5 others] (2016): Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress. Nat Commun. 2016; 7:10087
Open Access Logo

** Mathieu, R; Klatte, T; Lucca, I; Mbeutcha, A; Seitz, C; Karakiewicz, PI; Fajkovic, H; Sun, M; Lotan, Y; Scherr, DS; Montorsi, F; Briganti, A; Rouprêt, M; Margulis, V; Rink, M [and 8 others] (2016): Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study. BJU Int. 2016; 118(2):243-249

** Nivarthi, H; Gordziel, C; Themanns, M; Kramer, N; Eberl, M; Rabe, B; Schlederer, M; Rose-John, S; Knösel, T; Kenner, L; Freund, P; Aberger, F; Han, X; Kralovics, R; Dolznig, H [and 3 others] (2016): The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth. Oncotarget. 2016; 7(32):51096-51106
Open Access Logo

** Park, J; Kim, S; Joh, J; Remick, SC; Miller, DM; Yan, J; Kanaan, Z; Chao, JH; Krem, MM; Basu, SK; Hagiwara, S; Kenner, L; Moriggl, R; Bunting, KD; Tse, W (2016): MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling. Oncotarget. 2016; 7(28):43960-43973
Open Access Logo

** Pencik, J; Pham, HT; Schmoellerl, J; Javaheri, T; Schlederer, M; Culig, Z; Merkel, O; Moriggl, R; Grebien, F; Kenner, L (2016): JAK-STAT signaling in cancer: From cytokines to non-coding genome. Cytokine. 2016; 87:26-36
Open Access Logo

** Rodríguez-Carrasco, Y; Heilos, D; Richter, L; Süssmuth, RD; Heffeter, P; Sulyok, M; Kenner, L; Berger, W; Dornetshuber-Fleiss, R (2016): Mouse tissue distribution and persistence of the food-born fusariotoxins Enniatin B and Beauvericin. Toxicol Lett. 2016; 247:35-44
Open Access Logo

** Schinagl, A; Thiele, M; Douillard, P; Völkel, D; Kenner, L; Kazemi, Z; Freissmuth, M; Scheiflinger, F; Kerschbaumer, RJ (2016): Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer. Oncotarget. 2016; 7(45):73486-73496
Open Access Logo

** Sigl, V; Owusu-Boaitey, K; Joshi, PA; Kavirayani, A; Wirnsberger, G; Novatchkova, M; Kozieradzki, I; Schramek, D; Edokobi, N; Hersl, J; Sampson, A; Odai-Afotey, A; Lazaro, C; Gonzalez-Suarez, E; Pujana, MA [and 20 others] (2016): RANKL/RANK control Brca1 mutation-driven mammary tumors. Cell Res. 2016; 26(7):761-774
Open Access Logo

** Themanns, M; Mueller, KM; Kessler, SM; Golob-Schwarzl, N; Mohr, T; Kaltenecker, D; Bourgeais, J; Paier-Pourani, J; Friedbichler, K; Schneller, D; Schlederer, M; Zebedin-Brandl, E; Terracciano, LM; Han, X; Kenner, L [and 7 others] (2016): Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice. Sci Rep. 2016; 6:34719
Open Access Logo

** Turner, SD; Lamant, L; Kenner, L; Brugières, L (2016): Anaplastic large cell lymphoma in paediatric and young adult patients. Br J Haematol. 2016; 173(4):560-572

Conference Paper in Journal

** Hagiwara, S; Mine, S; Schiefer, AI; Kenner, L; Tse, W (2016): High expression of AF1Q is an adverse prognostic factor and a prediction marker of extramedullary disease in multiple myeloma. 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, Denmark, JUN 09-12, 2016. Haematologica (101), S1 530-530.

** Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Schlederer, M; Pham, HTT; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Muller, M; Rülicke, T; Moriggl, R (2016): Activated Stat5 Drives Peripheral T Cell Lymphomas. 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, Denmark, JUN 09-12, 2016. Haematologica (101), S1 567-567.

** Prutsch, N; Sanda, T; Wu, L; Turner, S; Jaeger, U; Staber, P; Steinberger, P; Moriggl, R; Mueller, M; Kenner, L; Merkel, O (2016): The TYK2-STAT1 pathway in aggressive T-Cell Lymphoma: A new therapeutic intervention site. Jahrestagung der ­Deutschen, Österreichischen und ­Schweizerischen ­Gesellschaften für Hämatologie und ­Medizinische Onkologie, Leipzig, Germany, Germany, OCT 14–18, 2016. Oncol Res Treat (39), S3 239-239.

Hartenbach, M; Baltzer, P; Hartenbach, S; Susani, M; Seitz, C; Kenner, L; Haug, A; Berroter-Infante, N; Wadsak, W; Mitterhauser, M; Pfaff, S; Ponholzer, A; Shariat, S; Hacker, M (2016): Staging primary prostate cancer with 68Ga-PSMA HBED-CC/[18F] Fluorocholine-PET/MRI. Society of Nuclear Medicine, New York, May 2016. Journal of Nuclear Medicine (57), S2 316-316.

Hartenbach, M; Baltzer, P; Hartenbach, S; Susani, M; Seitz, C; Kenner, L; Kramer, G; Haug, A; Berroterán-Infante, N; Wadsak, W; Mitterhauser, M; Pfaff, S; Rausch, I; Ponholzer, A; Shariat, S; Hacker, M (2016): Evaluation of dualtracer multiparametric PET/MRI parameters in primary prostate cancer. Society of Nuclear Medicine, New York, May 1, 2016. Journal of Nuclear Medicine (57), S2 610-610.

Kenner, L; Pencik, J; Hacker, M (2016): Impact of new technologies on malignant tumor management and therapy. EUSAAT 2016, Linz, Austria, AUG 24-27, 2016. AATEX Journal (5), 1 107-107.

Malcolm, T; Fairbairn, CJ; Hughes, K; Kenner, L; Burke, A; Turner, S (2016): Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells. American Association for Cancer Research, New Orelans, April 16-20, 2016. Cancer Research (76), 14 671-671.

Published (citable) presentations at scientific conferences (A2)

Crncec, I; Gordziel, C; Pathria, P; Modak, M; Stöckl, J; Wallner, B; Strobl, B; Leitner, N; Müller, M; Rauch, I; Decker, T; Schlederer, M; Kenner, L; Friedrich, K; Eferl, R (2016): The role of STAT1 in colitis-associated colorectal cancer. -Bridge Gaps Cross Roads - Joint Symposium of 4 PhD programs - CCHD, IAI, ICA, MCCA; FEB 1-3, 2016; Vienna, AUSTRIA.

Merkel, O; Aksoy, O; Suzani, M; Hassler, M; Schlangen, K; Balber, T; Mitterhauser, M; Moazzami, A; Schlederer, M; Turner, S; Egger, G; Hormann, G; Hacker, M; Culig, Z; Pencik, J; Kenner, L (2016): μ-Crystalline as hormone antagonist in prostate cancer. 7-7.-Androgens Biannual Meeting; SEP 15-17, 2016; Innsbruck.

Pencik, J; Schlederer, M; Gruber, W; Unger, C; Walker, SM; Chalaris, A; Marie, IJ; Hassler, MR; Javaheri, T; Aksoy, O; Blayney, JK; Prutsch, N; Skucha, A; Herac, M; Krämer, OH [and 25 others] (2016): Loss of IL-6/Stat3 Signaling Drives Metastatic Prostate Cancer in Mice and Men. -Keystone Symposium: Cytokine JAK-STAT Signaling in Immunity and Disease; Jan 10-14, 2016; Steamboat Springs, Colorado, USA.

Pencik, J; Schlederer, M; Malcolm, T; Turner, DS; Javaheri, T; Pham, HTT; Moriggl, R; Moazzami, A; Hacker, M; Kenner, L (2016): Metformin-resistance identifies metabolic reprogramming of senescence in cancer. -Annual LBI-CR SAB Meeting; NOV 28-29, 2016; Vienna, Austria.

Prutsch, N; Sanda, T; Turner, S; Wu, L; Müller, M; Jäger, U; Staber, P; Simonitsch-Klupp, I; Alvarez-Hernandez, A; Gurnhofer, E; Suske, T; Grebien, F; Stoiber, D; Schlederer, M; Moriggl, R [and 2 others] (2016): The TYK2-STAT1 pathway in aggressive T-Cell Lymphoma: A novel therapeutic intervention site? -Jahrestagung Österreichische Gesellschaft für Hämatologie und Onkologie (OeGHO); März 17-19, 2016; Vienna, Austria.

Weber, A; Pencik, J; Kenner, L; Klocker, H; Eder, IE (2016): Switch to succinate-mediated mitochondrial respiration associated with HIF-1 [alpha] stabilization in PTEN negative prostate cancer cells. 11-11.-Androgens Biannual Meeting; SEP 15-17, 2016; Innsbruck.

2015

Journal Article

** Berry, D; Kuzyk, O; Rauch, I; Heider, S; Schwab, C; Hainzl, E; Decker, T; Müller, M; Strobl, B; Schleper, C; Urich, T; Wagner, M; Kenner, L; Loy, A (2015): Intestinal Microbiota Signatures Associated with Inflammation History in Mice Experiencing Recurring Colitis. Front Microbiol. 2015; 6:1408
Open Access Logo

** Birner, P; Egger, G; Merkel, O; Kenner, L (2015): JunB and PTEN in prostate cancer: "loss is nothing else than change". Cell Death Differ. 2015; 22(4):522-523
Open Access Logo

** Grabner, B; Schramek, D; Mueller, KM; Moll, HP; Svinka, J; Hoffmann, T; Bauer, E; Blaas, L; Hruschka, N; Zboray, K; Stiedl, P; Nivarthi, H; Bogner, E; Gruber, W; Mohr, T [and 14 others] (2015): Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat Commun. 2015; 6:6285
Open Access Logo

** Hainzl, E; Stockinger, S; Rauch, I; Heider, S; Berry, D; Lassnig, C; Schwab, C; Rosebrock, F; Milinovich, G; Schlederer, M; Wagner, M; Schleper, C; Loy, A; Urich, T; Kenner, L [and 4 others] (2015): Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis. J Immunol. 2015; 195(10):5011-5024
Open Access Logo

** Kiss, I; Unger, C; Huu, CN; Atanasov, AG; Kramer, N; Chatruphonprasert, W; Brenner, S; McKinnon, R; Peschel, A; Vasas, A; Lajter, I; Kain, R; Saiko, P; Szekeres, T; Kenner, L [and 16 others] (2015): Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation. Cancer Lett. 2015; 356(2 Pt B):994-1006

** Merkel, O; Hamacher, F; Griessl, R; Grabner, L; Schiefer, AI; Prutsch, N; Baer, C; Egger, G; Schlederer, M; Krenn, PW; Hartmann, TN; Simonitsch-Klupp, I; Plass, C; Staber, PB; Moriggl, R [and 3 others] (2015): Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation. J Pathol. 2015; 236(4):445-456
Open Access Logo

** Minas, TZ; Han, J; Javaheri, T; Hong, SH; Schlederer, M; Saygideğer-Kont, Y; Çelik, H; Mueller, KM; Temel, I; Özdemirli, M; Kovar, H; Erkizan, HV; Toretsky, J; Kenner, L; Moriggl, R; Üren, A (2015): YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model. Oncotarget. 2015; 6(35):37678-37694
Open Access Logo

** Moti, N; Malcolm, T; Hamoudi, R; Mian, S; Garland, G; Hook, CE; Burke, GA; Wasik, MA; Merkel, O; Kenner, L; Laurenti, E; Dick, JE; Turner, SD (2015): Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin. Oncogene. 2015; 34(14):1843-1852

** Nivarthi, H; Prchal-Murphy, M; Swoboda, A; Hager, M; Schlederer, M; Kenner, L; Tuckermann, J; Sexl, V; Moriggl, R; Ermakova, O (2015): Stat5 gene dosage in T cells modulates CD8+ T-cell homeostasis and attenuates contact hypersensitivity response in mice. Allergy. 2015; 70(1):67-79

** Park, J; Schlederer, M; Schreiber, M; Ice, R; Merkel, O; Bilban, M; Hofbauer, S; Kim, S; Addison, J; Zou, J; Ji, C; Bunting, ST; Wang, Z; Shoham, M; Huang, G [and 10 others] (2015): AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis. Oncotarget. 2015; 6(24):20697-20710
Open Access Logo

** Pathria, P; Gotthardt, D; Prchal-Murphy, M; Putz, EM; Holcmann, M; Schlederer, M; Grabner, B; Crncec, I; Svinka, J; Musteanu, M; Hoffmann, T; Filipits, M; Berger, W; Poli, V; Kenner, L [and 8 others] (2015): Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice. Oncoimmunology. 2015; 4(4):e998529
Open Access Logo

** Pencik, J; Schlederer, M; Gruber, W; Unger, C; Walker, SM; Chalaris, A; Marié, IJ; Hassler, MR; Javaheri, T; Aksoy, O; Blayney, JK; Prutsch, N; Skucha, A; Herac, M; Krämer, OH [and 25 others] (2015): STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun. 2015; 6:7736
Open Access Logo

** Pencik, J; Schlederer, M; Gruber, W; Unger, C; Walker, SM; Chalaris, A; Marié, IJ; Hassler, MR; Javaheri, T; Aksoy, O; Blayney, JK; Prutsch, N; Skucha, A; Herac, M; Krämer, OH [and 25 others] (2015): Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun. 2015; 6:8802
Open Access Logo

** Pencik, J; Wiebringhaus, R; Susani, M; Culig, Z; Kenner, L (2015): IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer. Swiss Med Wkly. 2015; 145:w14215
Open Access Logo

** Rauch, I; Rosebrock, F; Hainzl, E; Heider, S; Majoros, A; Wienerroither, S; Strobl, B; Stockinger, S; Kenner, L; Müller, M; Decker, T (2015): Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons. Mol Cell Biol. 2015; 35(13):2332-2343

** Schiefer, AI; Vesely, P; Hassler, MR; Egger, G; Kenner, L (2015): The role of AP-1 and epigenetics in ALCL. Front Biosci (Schol Ed). 2015; 7:226-235

** Shalapour, S; Font-Burgada, J; Di Caro, G; Zhong, Z; Sanchez-Lopez, E; Dhar, D; Willimsky, G; Ammirante, M; Strasner, A; Hansel, DE; Jamieson, C; Kane, CJ; Klatte, T; Birner, P; Kenner, L; Karin, M (2015): Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 2015; 521(7550):94-98

Conference Paper in Journal

** Fairbairn, C; Malcolm, T; Hughes, K; Kenner, L; Turner, SD (2015): Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells. 5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Varese, ITALY, Italy, OCT 22, 2015. Brit J Haematol (171) 54-54.

** Hagiwara, S; Schiefer, AI; Mine, S; Kenner, L; Tse, W (2015): High Expression of AF1q Is an Adverse Prognostic Factor in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation. 55th Annual Meeting and Exposition of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013. Blood (126), 23

** Kenner, L; Kuroll, M; Hartmann, T; Krenn, P; Schlederer, M; Prutsch, N; Greil, R; Turner, S; Merkel, O (2015): PGDFR blockade as a novel therapy for NPM-ALK(+) anaplastic large cell lymphoma. 5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Varese, ITALY, Italy, OCT 22, 2015. Brit J Haematol (171) 28-28.

** Malcolm, T; Villarese, P; Fairbairn, C; Lamant, L; Trinquand, A; Hook, CE; Burke, GA; Brugieres, L; Hughes, K; Payet, D; Merkel, O; Schiefer, AI; Mian, S; Wasik, M; Turner, M [and 4 others] (2015): NPM-ALK mimics thymic pre-T cell receptor (TCR) expansion but requires transient TCR expression for thymic egress and peripheral anaplastic large cell lymphoma (ALCL) development. 5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Varese, ITALY, Italy, OCT 22, 2015. Brit J Haematol (171) 21-21.

** Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Prochazkova, J; Schlederer, M; Pham, H; Loizou, JI; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Müller, M [and 2 others] (2015): An activating STAT5 mutation is sufficient for Peripheral T Cell Lymphoma formation. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, Germany, OCT 11-14, 2015. Cytokine (76), 1 77-77.

** Pencik, J; Schlederer, M; Gruber, W; Unger, C; Walker, SM; Chalaris, A; Marie, I; Hassler, MR; Javaheri, T; Aksoy, O; Blayney, JK; Mazal, P; Grebien, F; Egger, G; Poli, V [and 19 others] (2015): Loss of IL-6/Stat3 signalling drives metastatic prostate cancer in mice and men. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, Germany, OCT 11-14, 2015. Cytokine (76), 1 112-112.

** Prutsch, N; Sanda, T; Turner, S; Kubicek, S; Boidol, B; Jaeger, U; Simonitsch-Klupp, I; Schiefer, AI; Mueller, M; Wu, L; Kenner, L; Merkel, O (2015): The Tyk2 Pathway as a Novel Therapeutic Intervention Site in Aggressive T-Cell Lymphoma. 20th Congress of European-Hematology-Association, Vienna, AUSTRIA, Austria, JUN 11-14, 2015. Haematologica (100), S1 108-108.

2014

Journal Article

** Berghoff, AS; Birner, P; Streubel, B; Kenner, L; Preusser, M (2014): ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC. APMIS. 2014; 122(9):867-872

** Birner, P; Bartsch, R; Schreiber, M; Dubsky, P; Kenner, L (2014): New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target? Future Oncol. 2014; 10(3):333-336

** Jais, A; Einwallner, E; Sharif, O; Gossens, K; Lu, TT; Soyal, SM; Medgyesi, D; Neureiter, D; Paier-Pourani, J; Dalgaard, K; Duvigneau, JC; Lindroos-Christensen, J; Zapf, TC; Amann, S; Saluzzo, S [and 20 others] (2014): Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. Cell. 2014; 158(1):25-40

** Leitner, NR; Lassnig, C; Rom, R; Heider, S; Bago-Horvath, Z; Eferl, R; Müller, S; Kolbe, T; Kenner, L; Rülicke, T; Strobl, B; Müller, M (2014): Inducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivo. PLoS One. 2014; 9(1):e86608
Open Access Logo

** Müller, S; Chen, Y; Ginter, T; Schäfer, C; Buchwald, M; Schmitz, LM; Klitzsch, J; Schütz, A; Haitel, A; Schmid, K; Moriggl, R; Kenner, L; Friedrich, K; Haan, C; Petersen, I [and 2 others] (2014): SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells. Oncotarget. 2014; 5(10):3184-3196
Open Access Logo

** Rao, S; Tortola, L; Perlot, T; Wirnsberger, G; Novatchkova, M; Nitsch, R; Sykacek, P; Frank, L; Schramek, D; Komnenovic, V; Sigl, V; Aumayr, K; Schmauss, G; Fellner, N; Handschuh, S [and 10 others] (2014): A dual role for autophagy in a murine model of lung cancer. Nat Commun. 2014; 5:3056

** Rauch, I; Hainzl, E; Rosebrock, F; Heider, S; Schwab, C; Berry, D; Stoiber, D; Wagner, M; Schleper, C; Loy, A; Urich, T; Müller, M; Strobl, B; Kenner, L; Decker, T (2014): Type I interferons have opposing effects during the emergence and recovery phases of colitis. Eur J Immunol. 2014; 44(9):2749-2760

** Schlederer, M; Mueller, KM; Haybaeck, J; Heider, S; Huttary, N; Rosner, M; Hengstschläger, M; Moriggl, R; Dolznig, H; Kenner, L (2014): Reliable quantification of protein expression and cellular localization in histological sections. PLoS One. 2014; 9(7):e100822
Open Access Logo

** Schwab, C; Berry, D; Rauch, I; Rennisch, I; Ramesmayer, J; Hainzl, E; Heider, S; Decker, T; Kenner, L; Müller, M; Strobl, B; Wagner, M; Schleper, C; Loy, A; Urich, T (2014): Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. ISME J. 2014; 8(5):1101-1114
Open Access Logo

** Ye, X; Shokrollahi, K; Rozen, WM; Conyers, R; Wright, P; Kenner, L; Turner, SD; Whitaker, IS (2014): Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence. Mutat Res Rev Mutat Res. 2014; 762:123-132

Conference Paper in Journal

** Javaheri, T; Sax, B; Nivarthi, H; Tomazou, E; Mikula, M; Pencik, J; Kazemi, Z; Kauer, M; Wiedner, M; Tuckermann, J; Schlederer, M; Kenner, L; Erben, R; Logan, M; Hartmann, C [and 2 others] (2014): A mouse model for small round cell tumors induced by the Ewing sarcoma oncogene EWS/FLI1. 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), San Diego, CA, United States, APR 05-09, 2014. Cancer Res (74), 19

2013

Journal Article

** Kollmann, K; Heller, G; Schneckenleithner, C; Warsch, W; Scheicher, R; Ott, RG; Schäfer, M; Fajmann, S; Schlederer, M; Schiefer, AI; Reichart, U; Mayerhofer, M; Hoeller, C; Zöchbauer-Müller, S; Kerjaschki, D [and 9 others] (2013): A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell. 2013; 24(2):167-181
Open Access Logo

** McGuckin, CP; Jurga, M; Miller, AM; Sarnowska, A; Wiedner, M; Boyle, NT; Lynch, MA; Jablonska, A; Drela, K; Lukomska, B; Domanska-Janik, K; Kenner, L; Moriggl, R; Degoul, O; Perruisseau-Carrier, C; Forraz, N (2013): Ischemic brain injury: a consortium analysis of key factors involved in mesenchymal stem cell-mediated inflammatory reduction. Arch Biochem Biophys. 2013; 534(1-2):88-97

Published (citable) presentations at scientific conferences (A2)

Kollmann, K; Heller, G; Schneckenleithner, C; Warsch, W; Scheicher, R; Ott, R; Schäfer, M; Fajmann, S; Schlederer, M; Schiefer, AI; Reichart, U; Mayerhofer, M; Hoeller, C; Zoechbauer-Mueller, S; Kerjaschki, D [and 9 others] (2013): A new kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. -FASEB Science Research Conferences: Hematologic Malignancies; AUG 4-9, 2013; Vermont, USA.

2012

Journal Article

** Berry, D; Schwab, C; Milinovich, G; Reichert, J; Ben Mahfoudh, K; Decker, T; Engel, M; Hai, B; Hainzl, E; Heider, S; Kenner, L; Müller, M; Rauch, I; Strobl, B; Wagner, M [and 3 others] (2012): Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J. 2012; 6(11):2091-2106
Open Access Logo

** Friedbichler, K; Themanns, M; Mueller, KM; Schlederer, M; Kornfeld, JW; Terracciano, LM; Kozlov, AV; Haindl, S; Kenner, L; Kolbe, T; Mueller, M; Snibson, KJ; Heim, MH; Moriggl, R (2012): Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer. Hepatology. 2012; 55(3):941-952

** Hadzijusufovic, E; Peter, B; Herrmann, H; Rülicke, T; Cerny-Reiterer, S; Schuch, K; Kenner, L; Thaiwong, T; Yuzbasiyan-Gurkan, V; Pickl, WF; Willmann, M; Valent, P (2012): NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation. Allergy. 2012; 67(7):858-868
Open Access Logo

** Klymiuk, I; Kenner, L; Adler, T; Busch, DH; Boersma, A; Irmler, M; Fridrich, B; Gailus-Durner, V; Fuchs, H; Leitner, N; Müller, M; Kühn, R; Schlederer, M; Treise, I; de Angelis, MH; Beckers, J (2012): In vivo functional requirement of the mouse Ifitm1 gene for germ cell development, interferon mediated immune response and somitogenesis. PLoS One. 2012; 7(10):e44609
Open Access Logo

** Laimer, D; Dolznig, H; Kollmann, K; Vesely, PW; Schlederer, M; Merkel, O; Schiefer, AI; Hassler, MR; Heider, S; Amenitsch, L; Thallinger, C; Staber, PB; Simonitsch-Klupp, I; Artaker, M; Lagger, S [and 23 others] (2012): PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med. 2012; 18(11):1699-1704

** Musteanu, M; Blaas, L; Zenz, R; Svinka, J; Hoffmann, T; Grabner, B; Schramek, D; Kantner, HP; Müller, M; Kolbe, T; Rülicke, T; Moriggl, R; Kenner, L; Stoiber, D; Penninger, JM [and 3 others] (2012): A mouse model to identify cooperating signaling pathways in cancer. Nat Methods. 2012; 9(9):897-900

2011

** Jurkin, J; Zupkovitz, G; Lagger, S; Grausenburger, R; Hagelkruys, A; Kenner, L; Seiser, C (2011): Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis. Cell Cycle. 2011; 10(3):406-412
Open Access Logo

** Leeb, C; Jurga, M; McGuckin, C; Forraz, N; Thallinger, C; Moriggl, R; Kenner, L (2011): New perspectives in stem cell research: beyond embryonic stem cells. Cell Proliferat. 2011; 44: 9-14.

** Mueller, KM; Kornfeld, JW; Friedbichler, K; Blaas, L; Egger, G; Esterbauer, H; Hasselblatt, P; Schlederer, M; Haindl, S; Wagner, KU; Engblom, D; Haemmerle, G; Kratky, D; Sexl, V; Kenner, L [and 8 others] (2011): Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. Hepatology. 2011; 54(4):1398-1409
Open Access Logo

Conference Paper in Journal

** Hainzl, E; Rauch, I; Heider, S; Kenner, L; Decker, T; Strobl, B; Müller, M (2011): Tyrosine kinase 2 protects from chemically-induced colitis via amplification of interleukin-22 signalling. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, Italy, OCT 09-12, 2011. Cytokine (56), S1 32-32.

** Kenner, L; Laimer, D; Dolznig, H; Vesely, P; Kollmann, K; Schiefer, AII; Sexl, V; Staber, PB; Hoefler, G; Penninger, J; Inghirami, G; Ulrich, J (2011): New and Highly Efficient Therapy for Treatment NPM-ALK Associated Lymphomas. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego, CA, United States, DEC 10-13, 2011. Blood (118), 21 721-721.

** Nivarthi, H; Tsyrulnyk, A; Warsch, W; Wang, ZQ; Winkler, S; Kenner, L; Müller, M; Baum, C; Bunting, KD; Sexl, V; Rülicke, T; Moriggl, R (2011): Generation of a Transgenic Mouse with Inducible Constitutively Active Stat5a. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego, CA, United States, DEC 10-13, 2011. Blood (118), 21 1456-1456.

Published (citable) presentations at scientific conferences (A2)

Hainzl, E; Rauch, I; Heider, S; Kenner, L; Decker, T; Strobl, B; Müller, M (2011): Tyrosine kinase 2 protects from chemically-induced colitis via amplification of interleukin-22 signalling. -9th Joint Meeting of the ICS/ISICR; Okt 9-12, 2011; Florence, Italy.

Rauch, I; Hainzl, E; Heider, S; Strobl, B; Müller, M; Kenner, L; Decker, T (2011): Type I Interferons interfere with resolving inflammation of DSS induced acute colonic disease. -Microbiota and mucosal immunology: The interface in health and disease; April 14-16, 2011; San Francisco USA.

2010

Journal Article

** Blaas, L; Kornfeld, JW; Schramek, D; Musteanu, M; Zollner, G; Gumhold, J; van Zijl, F; Schneller, D; Esterbauer, H; Egger, G; Mair, M; Kenner, L; Mikulits, W; Eferl, R; Moriggl, R [and 3 others] (2010): Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis. Hepatology. 2010; 51(4):1319-1326

** Lagger, S; Meunier, D; Mikula, M; Brunmeir, R; Schlederer, M; Artaker, M; Pusch, O; Egger, G; Hagelkruys, A; Mikulits, W; Weitzer, G; Muellner, EW; Susani, M; Kenner, L; Seiser, C (2010): Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans. Embo J. 2010; 29(23):3992-4007
Open Access Logo

** Leeb, C; Jurga, M; McGuckin, C; Moriggl, R; Kenner, L (2010): Promising new sources for pluripotent stem cells. Stem Cell Rev Rep. 2010; 6(1):15-26

** Musteanu, M; Blaas, L; Mair, M; Schlederer, M; Bilban, M; Tauber, S; Esterbauer, H; Mueller, M; Casanova, E; Kenner, L; Poli, V; Eferl, R (2010): Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. Gastroenterology. 2010; 138(3):1003-11.e1-5

2009

** Ecker, A; Simma, O; Hoelbl, A; Kenner, L; Beug, H; Moriggl, R; Sexl, V (2009): The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor. Front Biosci (Landmark Ed). 2009; 14:2944-2958

** Pflegerl, P; Vesely, P; Hantusch, B; Schlederer, M; Zenz, R; Janig, E; Steiner, G; Meixner, A; Petzelbauer, P; Wolf, P; Soleiman, A; Egger, G; Moriggl, R; Kishimoto, T; Wagner, EF; Kenner, L (2009): Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci U S A. 2009; 106(48):20423-20428

2008

** Harir, N; Boudot, C; Friedbichler, K; Sonneck, K; Kondo, R; Martin-Lannerée, S; Kenner, L; Kerenyi, M; Yahiaoui, S; Gouilleux-Gruart, V; Gondry, J; Bénit, L; Dusanter-Fourt, I; Lassoued, K; Valent, P [and 2 others] (2008): Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade. Blood (112), 6 2463-2473.

** Kornfeld, JW; Grebien, F; Kerenyi, MA; Friedbichler, K; Kovacic, B; Zankl, B; Hoelbl, A; Nivarti, H; Beug, H; Sexl, V; Muller, M; Kenner, L; Mullner, EW; Gouilleux, F; Moriggl, R (2008): The different functions of Stat5 and chromatin alteration through Stat5 proteins. Front Biosci. 2008; 13:6237-6254
Open Access Logo

2007

** Staber, PB; Vesely, P; Haq, N; Ott, RG; Funato, K; Bambach, I; Fuchs, C; Schauer, S; Linkesch, W; Hrzenjak, A; Dirks, WG; Sexl, V; Bergler, H; Kadin, ME; Sternberg, DW [and 2 others] (2007): The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. Blood. 2007; 110(9):3374-3383
Open Access Logo

2005

** Moriggl, R; Sexl, V; Kenner, L; Duntsch, C; Stangl, K; Gingras, S; Hoffmeyer, A; Bauer, A; Piekorz, R; Wang, D; Bunting, KD; Wagner, EF; Sonneck, K; Valent, P; Ihle, JN; Beug, H (2005): Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell (7), 1 87-99.

2003

** Szremska, AP; Kenner, L; Weisz, E; Ott, RG; Passegué, E; Artwohl, M; Freissmuth, M; Stoxreiter, R; Theussl, HC; Parzer, SB; Moriggl, R; Wagner, EF; Sexl, V (2003): JunB inhibits proliferation and transformation in B-lymphoid cells. Blood. 2003; 102(12):4159-4165

© University of Veterinary Medicine ViennaHelp and DownloadsAccessibility statement